cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA249165 | .a | 3459 to 3637 | 1 to 179 | 179/179 (100 %) | 1 diff (99.5 %id) | ||||
AA359612 | lung | .a | 2242 to 2593 | 1 to 353 | 353/353 (100 %) | 1 diff (99.8 %id) | |||
AA368630 | placenta | .a | 2084 to 2321 | 1 to 237 | 237/237 (100 %) | 1 diff (99.6 %id) | |||
AA377226 | small intestine | .a | 2617 to 2898 | 1 to 283 | 283/283 (100 %) | 2 diff (99.3 %id) | |||
AB065087 | .a | 2103 to 4126 | 1 to 2023 | AAA | 2023/2023 (100 %) | 2 diff (100.0 %id) | |||
AI207527 | Liver | .e-u | 1 to 580 | 577 to 1 | exact | tiling clone, | 577/577 (100 %) | 6 diff (99.0 %id) | |
AJ708047 | heart | .a | 1132 to 1663 | 21 to 552 | 532/552 (96 %) | 6 diff (99.0 %id) | |||
AK094193 | .a | 491 to 4126 | 1 to 3636 | available from FLJ, | 3636/3636 (100 %) | 0 diff (100 %id) | |||
AK127649 | Liver | .a | 1560 to 4126 | 1 to 2567 | available from FLJ, | 2567/2567 (100 %) | 2 diff (100.0 %id) | ||
AL831992 | human skeletal muscle | .a | 61 to 4126 | 1 to 4066 | K735R | tiling clone, available from DKFZ, AAA | 4066/4066 (100 %) | 6 diff (99.9 %id) | |
DA033238 | .a | 492 to 1059 | 2 to 569 | capped | 568/568 (100 %) | 0 diff (100 %id) | |||
DB295836 | .a | 3585 to 4126 | 543 to 1 | 543/543 (100 %) | 1 diff (99.9 %id) | ||||
AW369665 | breast | .a | 1740 to 2305 | 1 to 564 | 564/564 (100 %) | 8 diff (98.6 %id) | |||
AW389533 | stomach | .a | 2517 to 3071 | 1 to 554 | 554/554 (100 %) | 8 diff (98.6 %id) | |||
AW754180 | colon | .a | 158 to 528 | 371 to 1 | 371/372 (99 %) | 14 diff (96.3 %id) | |||
AW880873 | ovary | .a | 564 to 1129 | 565 to 2 | 564/565 (99 %) | 0 diff (100 %id) | |||
AW881139 | ovary | .a | 266 to 689 | 1 to 425 | 425/425 (100 %) | 3 diff (99.3 %id) | |||
AW947402 | lung_tumor | .a | 3478 to 3933 | 455 to 1 | Submitted on the opposite strand | 455/455 (100 %) | 3 diff (99.4 %id) | ||
AW956344 | .a | 2618 to 3304 | 1 to 687 | 687/687 (100 %) | 11 diff (98.4 %id) | ||||
AW962603 | .a | 2084 to 2456 | 1 to 373 | 373/504 (74 %) | 1 diff (99.9 %id) | ||||
AW976941 | .a | 3943 to 4126 | 184 to 1 | Submitted on the opposite strand | 184/304 (60 %) | 8 diff (97.4 %id) | |||
AW995271 | breast_normal | .a | 3183 to 3739 | 557 to 1 | Submitted on the opposite strand | 557/557 (100 %) | 9 diff (98.4 %id) | ||
AX810689 | .a | 1786 to 4131 | 1 to 2346 | 2346/2350 (99 %) | 4 diff (99.9 %id) | ||||
BC065264 | Uterus, leiomyosarcoma | .a | 508 to 4126 | 1 to 3619 | available from MGC, AAA | 3619/3619 (100 %) | 0 diff (100 %id) | ||
BC109038 | PCR rescued clones | .a | 547 to 3770 | 1 to 3224 | 3224/3224 (100 %) | 0 diff (100 %id) | |||
BC109039 | PCR rescued clones | .a | 547 to 3770 | 1 to 3224 | 3224/3224 (100 %) | 0 diff (100 %id) | |||
BE061072 | breast | .a | 1731 to 1915 | 1 to 187 | 187/187 (100 %) | 16 diff (91.5 %id) | |||
BE090367 | breast | .a | 2926 to 3323 | 398 to 1 | Submitted on the opposite strand | 398/398 (100 %) | 4 diff (99.0 %id) | ||
BE150853 | head_neck | .c | 1 to 496 | 502 to 9 | Q104* | tiling clone, | Submitted on the opposite strand | 494/505 (97 %) | 2 diff (99.7 %id) |
BE150885 | head_neck | .a | 1807 to 2275 | 498 to 32 | Submitted on the opposite strand | 467/509 (91 %) | 5 diff (99.1 %id) | ||
BE151239 | head_neck | .a | 1806 to 2285 | 521 to 42 | Submitted on the opposite strand | 480/524 (91 %) | 3 diff (99.5 %id) | ||
BE700853 | nervous_normal | .a | 1323 to 1757 | 1 to 433 | 433/433 (100 %) | 1 diff (99.8 %id) | |||
BE700858 | nervous_normal | .a | 1395 to 1816 | 426 to 8 | 419/426 (98 %) | 1 diff (99.8 %id) | |||
BE700859 | nervous_normal | .a | 1412 to 1816 | 416 to 13 | 404/416 (97 %) | 0 diff (100 %id) | |||
BE700888 | nervous_normal | .a | 1461 to 1816 | 375 to 19 | 357/375 (95 %) | 1 diff (99.8 %id) | |||
BE700889 | nervous_normal | .a | 1328 to 1817 | 499 to 11 | 489/499 (97 %) | 0 diff (100 %id) | |||
BE700894 | nervous_normal | .a | 1384 to 1816 | 433 to 1 | 433/433 (100 %) | 3 diff (99.4 %id) | |||
BE700921 | nervous_normal | .a | 1432 to 1817 | 387 to 3 | 385/387 (99 %) | 0 diff (100 %id) | |||
BE700925 | nervous_normal | .a | 1413 to 1791 | 379 to 1 | 379/379 (100 %) | 3 diff (99.3 %id) | |||
BE700926 | nervous_normal | .a | 1415 to 1816 | 407 to 6 | 402/407 (98 %) | 0 diff (100 %id) | |||
BE717229 | head_neck | .a | 3655 to 3871 | 223 to 7 | 217/227 (95 %) | 0 diff (100 %id) | |||
BE772085 | prostate_tumor | .a | 1306 to 1713 | 1 to 410 | 410/410 (100 %) | 18 diff (95.7 %id) | |||
BE818893 | breast_normal | .a | 1506 to 1815 | 321 to 10 | 312/321 (97 %) | 3 diff (99.1 %id) | |||
BE818894 | breast_normal | .a | 1517 to 1817 | 304 to 2 | 303/304 (99 %) | 3 diff (99.1 %id) | |||
BE818902 | breast_normal | .a | 1386 to 1815 | 439 to 12 | 428/439 (97 %) | 6 diff (98.7 %id) | |||
BE818903 | breast_normal | .a | 1497 to 1815 | 334 to 16 | 319/334 (95 %) | 4 diff (98.9 %id) | |||
BE818906 | breast_normal | .a | 1535 to 1815 | 288 to 10 | 279/288 (96 %) | 7 diff (97.6 %id) | |||
BE818908 | breast_normal | .a | 1395 to 1811 | 427 to 6 | 420/427 (98 %) | 9 diff (97.9 %id) | |||
BE818909 | breast_normal | .a | 1454 to 1816 | 363 to 3 | 361/363 (99 %) | 10 diff (97.3 %id) | |||
BE818931 | breast_normal | .a | 1359 to 1816 | 460 to 6 | 455/460 (98 %) | 3 diff (99.4 %id) | |||
BE818938 | breast_normal | .a | 1366 to 1808 | 439 to 1 | 439/439 (100 %) | 6 diff (98.7 %id) | |||
BE818939 | breast_normal | .a | 1507 to 1815 | 320 to 14 | 307/320 (95 %) | 4 diff (98.8 %id) | |||
BE818941 | breast_normal | .a | 1381 to 1809 | 428 to 1 | 428/428 (100 %) | 3 diff (99.3 %id) | |||
BE818942 | breast_normal | .a | 1445 to 1818 | 377 to 6 | 372/381 (97 %) | 4 diff (99.0 %id) | |||
BE818961 | breast_normal | .a | 1316 to 1668 | 8 to 357 | 350/357 (98 %) | 7 diff (98.1 %id) | |||
BE818963 | breast_normal | .a | 1495 to 1817 | 337 to 14 | 323/337 (95 %) | 9 diff (97.4 %id) | |||
BE818967 | breast_normal | .a | 1399 to 1815 | 430 to 16 | 415/430 (96 %) | 4 diff (99.1 %id) | |||
BE818968 | breast_normal | .a | 1424 to 1815 | 413 to 20 | 394/413 (95 %) | 3 diff (99.3 %id) | |||
BE818969 | breast_normal | .a | 1401 to 1817 | 419 to 3 | 372/419 (88 %) | 6 diff (98.6 %id) | |||
BE818971 | breast_normal | .a | 1409 to 1812 | 414 to 11 | 404/414 (97 %) | 3 diff (99.3 %id) | |||
BE818975 | breast_normal | .a | 1445 to 1815 | 384 to 15 | 370/384 (96 %) | 2 diff (99.5 %id) | |||
BE818979 | breast_normal | .a | 1418 to 1809 | 397 to 6 | 392/397 (98 %) | 6 diff (98.5 %id) | |||
BE827584 | lung_tumor | .a | 1621 to 2032 | 62 to 471 | 410/471 (87 %) | 6 diff (98.8 %id) | |||
BE830922 | marrow | .a | 1390 to 1817 | 431 to 2 | 428/431 (99 %) | 1 diff (99.8 %id) | |||
BE830924 | marrow | .a | 1410 to 1819 | 416 to 6 | 411/416 (98 %) | 1 diff (99.8 %id) | |||
BE830925 | marrow | .a | 1400 to 1726 | 349 to 20 | 330/349 (94 %) | 2 diff (99.5 %id) | |||
BE830926 | marrow | .a | 1394 to 1728 | 355 to 22 | 334/355 (94 %) | 0 diff (100 %id) | |||
BF170892 | blood | .a | 1005 to 1114 | 1 to 113 | 113/117 (96 %) | 6 diff (94.9 %id) | |||
BF740780 | bocio_tumor | .a | 1308 to 1733 | 16 to 441 | 426/441 (96 %) | 7 diff (98.5 %id) | |||
BF756593 | colon | .a | 930 to 1243 | 319 to 5 | Submitted on the opposite strand | 315/319 (98 %) | 0 diff (100 %id) | ||
BF804739 | colon_ins | .a | 3319 to 3678 | 377 to 18 | Submitted on the opposite strand | 360/377 (95 %) | 0 diff (100 %id) | ||
BF805364 | colon_ins | .a | 3496 to 3902 | 405 to 1 | Submitted on the opposite strand | 405/405 (100 %) | 4 diff (99.1 %id) | ||
BF821858 | kidney_tumor | .a | 1226 to 1478 | 1 to 252 | 252/252 (100 %) | 3 diff (98.9 %id) | |||
BF852050 | lung_normal | .a | 3597 to 3953 | 359 to 2 | Submitted on the opposite strand | 358/359 (99 %) | 11 diff (97.0 %id) | ||
BF852350 | lung_normal | .a | 3445 to 3973 | 530 to 3 | Submitted on the opposite strand | 528/530 (99 %) | 0 diff (100 %id) | ||
BF996091 | placenta_normal | .a | 3065 to 3373 | 306 to 1 | 306/306 (100 %) | 8 diff (97.4 %id) | |||
BF999990 | placenta_normal | .a | 3010 to 3379 | 390 to 23 | 368/390 (94 %) | 0 diff (100 %id) | |||
BG314917 | .a | 1917 to 2147 | 1 to 232 | 232/232 (100 %) | 1 diff (99.6 %id) | ||||
BG315000 | .a | 2227 to 2453 | 227 to 1 | 227/227 (100 %) | 8 diff (96.5 %id) | ||||
BI002580 | head_normal | .a | 3365 to 3514 | 152 to 4 | 149/152 (98 %) | 8 diff (94.8 %id) | |||
BI021832 | marrow | .a | 2101 to 2626 | 13 to 542 | 530/542 (97 %) | 16 diff (97.1 %id) | |||
BI030490 | marrow | .a | 2347 to 2693 | 347 to 1 | 347/347 (100 %) | 1 diff (99.8 %id) | |||
BQ337222 | marrow | .a | 974 to 1175 | 1 to 205 | 205/230 (89 %) | 9 diff (96.1 %id) | |||
BQ347205 | nervous_tumor | .a | 941 to 1426 | 508 to 23 | 486/508 (95 %) | 0 diff (100 %id) | |||
DA190363 | amygdala | .a | 62 to 662 | 2 to 602 | capped | 601/601 (100 %) | 0 diff (100 %id) | ||
DA268722 | caudate nucleus | .a | 254 to 825 | 2 to 573 | capped | 572/572 (100 %) | 1 diff (99.9 %id) | ||
DA298749 | hippocampus | .a | 1316 to 1893 | 2 to 580 | capped | 579/579 (100 %) | 4 diff (99.4 %id) | ||
DA310401 | hippocampus | .a | 39 to 609 | 2 to 572 | capped | 571/572 (99 %) | 1 diff (99.9 %id) | ||
DC335069 | hippocampus | .a | 24 to 613 | 1 to 590 | 590/590 (100 %) | 1 diff (99.9 %id) | |||
DA384807 | thalamus | .a | 1457 to 2051 | 2 to 596 | capped | 595/595 (100 %) | 0 diff (100 %id) | ||
C21540 | .a | 3824 to 4032 | 1 to 209 | 209/211 (99 %) | 4 diff (98.2 %id) | ||||
CN285424 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 2830 to 3422 | 1 to 592 | 592/592 (100 %) | 3 diff (99.5 %id) | |||
CN420884 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 40 to 555 | 1 to 516 | 516/516 (100 %) | 1 diff (99.9 %id) | |||
CN420885 | embryonic stem cells, DMSO-treated H9 cellline | .a | 29 to 202 | 1 to 174 | 174/174 (100 %) | 1 diff (99.5 %id) | |||
CN420886 | embryonic stem cells, DMSO-treated H9 cellline | .a | 1084 to 1878 | 1 to 797 | 797/801 (99 %) | 6 diff (99.3 %id) | |||
CR610274 | T cells (Jurkat cell line) Cot10-normalized | .a | 3511 to 4131 | 1 to 621 | 621/621 (100 %) | 0 diff (100 %id) | |||
BX410092 | T cells (Jurkat cell line) | .a | 816 to 1715 | 1 to 897 | 897/897 (100 %) | 10 diff (98.9 %id) | |||
BX435972 | T cells (Jurkat cell line) | .a | 3349 to 4124 | 781 to 1 | 781/882 (88 %) | 37 diff (95.9 %id) | |||
BX462519 | T cells (Jurkat cell line) | .a | 43 to 1061 | 1 to 1013 | 1013/1013 (100 %) | 24 diff (97.7 %id) | |||
BX383704 | .a | 3511 to 4131 | 1 to 622 | 622/622 (100 %) | 6 diff (99.1 %id) | ||||
CV351004 | colon | .b | 1144 to 1725 | 615 to 38 | Submitted on the opposite strand | 578/683 (84 %) | 0 diff (100 %id) | ||
BX491397 | .a | 3453 to 4126 | 692 to 19 | AAA | 674/674 (100 %) | 0 diff (100 %id) | |||
DN916141 | .b | 691 to 1237 | 1 to 547 | tiling clone, | 547/547 (100 %) | 2 diff (99.7 %id) | |||
DN916142 | .b | 1369 to 1977 | 601 to 1 | tiling clone, | 601/607 (99 %) | 8 diff (98.7 %id) | |||
EH316254. matches multiple genes | .a | 388 to 450 | 1 to 64 | tiling clone, | also hits gene sherswee | 64/65 (98 %) | 5 diff (92.4 %id) | ||
FN061706 | breast carcinoma | .a | 3330 to 3419 | 1 to 87 | 87/88 (98 %) | 3 diff (96.6 %id) | |||
FN066882 | breast carcinoma | .a | 2155 to 2218 | 1 to 65 | 65/65 (100 %) | 1 diff (98.5 %id) | |||
FN079685 | breast carcinoma | .a | 3868 to 3943 | 76 to 1 | Submitted on the opposite strand | 76/77 (98 %) | 0 diff (100 %id) | ||
FN081751 | breast carcinoma | .a | 3625 to 3685 | 1 to 61 | 61/64 (95 %) | 1 diff (98.5 %id) | |||
FN153910 | breast carcinoma | .b | 1929 to 1995 | 65 to 1 | tiling clone, | Submitted on the opposite strand | 65/66 (98 %) | 2 diff (97.0 %id) | |
GD142803 | .a | 2938 to 3132 | 1 to 195 | 195/198 (98 %) | 2 diff (99.0 %id) | ||||
GD158766 | .a | 3960 to 4126 | 1 to 167 | AAA | 167/167 (100 %) | 6 diff (96.5 %id) | |||
GD158860 | .a | 3958 to 4126 | 1 to 169 | AAA | 169/169 (100 %) | 8 diff (95.3 %id) | |||
AV693943 | hepatocellular carcinoma | .a | 3225 to 3357 | 256 to 386 | 350/386 (90 %) | 33 diff (91.5 %id) | |||
DB458343 | testis | .a | -8 to 336 | 1 to 345 | tiling clone, | 345/345 (100 %) | 3 diff (99.2 %id) | ||
DA567383 | .a | 25 to 541 | 2 to 518 | capped | 517/517 (100 %) | 2 diff (99.7 %id) | |||
R60069 | whole brain | .a | 3659 to 4131 | 487 to 5 | 483/511 (94 %) | 0 diff (100 %id) | |||
R60133 | whole brain | .a | 2740 to 3214 | 1 to 485 | 485/488 (99 %) | 15 diff (97.0 %id) | |||
T83665 | liver and spleen | .a | 2638 to 3144 | 512 to 1 | 512/512 (100 %) | 19 diff (96.3 %id) | |||
H94353 | placenta | .a | 3532 to 3846 | 1 to 320 | 320/322 (99 %) | 13 diff (96.0 %id) | |||
N35083 | melanocyte | .a | 2750 to 3128 | 383 to 1 | 383/427 (89 %) | 2 diff (99.6 %id) | |||
N43823 | melanocyte | .a | 1021 to 1368 | 1 to 349 | 349/349 (100 %) | 1 diff (99.8 %id) | |||
N33854 | melanocyte | .a | 2609 to 3128 | 524 to 1 | 524/526 (99 %) | 5 diff (99.1 %id) | |||
N67562 | cochlea, ear | .a | 3734 to 4124 | 394 to 1 | 394/394 (100 %) | 5 diff (98.8 %id) | |||
AA707195 | liver and spleen | .a | 3599 to 4047 | 449 to 1 | 449/449 (100 %) | 0 diff (100 %id) | |||
AA179756 | .a | 316 to 693 | 1 to 378 | 378/379 (99 %) | 1 diff (99.8 %id) | ||||
AA180333 | .a | 3700 to 4125 | 427 to 1 | 427/428 (99 %) | 1 diff (99.8 %id) | ||||
AA227714 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 3077 to 3468 | 1 to 390 | 390/390 (100 %) | 2 diff (99.5 %id) | |||
AA227960 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 3727 to 4126 | 400 to 1 | 400/400 (100 %) | 0 diff (100 %id) | |||
AA234587 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 3077 to 3434 | 1 to 359 | 359/359 (100 %) | 2 diff (99.5 %id) | |||
AA406642 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 3674 to 4128 | 455 to 1 | 455/455 (100 %) | 0 diff (100 %id) | |||
AA609954 | .a | 2918 to 3128 | 241 to 31 | AAA | Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) | 211/211 (100 %) | 0 diff (100 %id) | ||
AA633160 | colon, colon tumor RER+ | .a | 2847 to 3127 | 281 to 1 | 281/281 (100 %) | 0 diff (100 %id) | |||
AA765123 | germinal center B cell | .a | 3720 to 4126 | 430 to 24 | AAA | 407/407 (100 %) | 0 diff (100 %id) | ||
AA843533 | parathyroid gland, parathyroid tumor | .a | 3593 to 4126 | 546 to 13 | AAA | 534/534 (100 %) | 0 diff (100 %id) | ||
AA911919 | adenocarcinoma, colon | .a | 2918 to 3127 | 210 to 1 | 210/210 (100 %) | 0 diff (100 %id) | |||
AA911920 | adenocarcinoma, colon | .a | 2815 to 3127 | 313 to 1 | 313/313 (100 %) | 0 diff (100 %id) | |||
AA862001 | squamous cell carcinoma from base of tongue, tongue | .a | 3811 to 4126 | 316 to 1 | 316/316 (100 %) | 0 diff (100 %id) | |||
AA923774 | pooled | .a | 3722 to 4125 | 404 to 1 | 404/404 (100 %) | 3 diff (99.3 %id) | |||
AI218736 | pooled | .a | 3692 to 4131 | 443 to 4 | 440/443 (99 %) | 0 diff (100 %id) | |||
AI034302 | senescent fibroblast | .a | 3779 to 4126 | 362 to 15 | AAA | 348/348 (100 %) | 2 diff (99.5 %id) | ||
AI149261 | uterus | .a | 3698 to 4131 | 441 to 5 | 437/443 (98 %) | 0 diff (100 %id) | |||
AI221573 | placenta | .a | 3819 to 4126 | 308 to 1 | 308/308 (100 %) | 1 diff (99.7 %id) | |||
AI306129 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 2745 to 3128 | 395 to 12 | AAA | Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) | 384/384 (100 %) | 2 diff (99.5 %id) | |
AI262308 | adenocarcinoma, colon | .a | 3720 to 4129 | 410 to 1 | 410/410 (100 %) | 0 diff (100 %id) | |||
AI281064 | adenocarcinoma, colon | .a | 3706 to 4129 | 424 to 1 | 424/424 (100 %) | 5 diff (98.9 %id) | |||
AI302415 | 2 pooled tumors (clear cell type), Kidney | .a | 2881 to 3131 | 251 to 1 | 251/251 (100 %) | 0 diff (100 %id) | |||
AI346969 | adenocarcinoma, colon | .a | 3635 to 4129 | 497 to 1 | 497/497 (100 %) | 4 diff (99.2 %id) | |||
AI266734 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 3723 to 4126 | 404 to 1 | 404/404 (100 %) | 0 diff (100 %id) | |||
AI332623 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 3650 to 4126 | 477 to 1 | 477/477 (100 %) | 0 diff (100 %id) | |||
AI352401 | pooled germ cell tumors | .a | 3818 to 4126 | 322 to 14 | AAA | 309/309 (100 %) | 0 diff (100 %id) | ||
AI365203 | pooled germ cell tumors | .a | 2940 to 3143 | 219 to 16 | AAA | Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) | 204/204 (100 %) | 1 diff (99.6 %id) | |
AI253097 | Kidney | .a | 3723 to 4126 | 417 to 14 | AAA | 404/404 (100 %) | 2 diff (99.6 %id) | ||
AI565227 | pooled | .a | 3900 to 4126 | 227 to 1 | 227/227 (100 %) | 0 diff (100 %id) | |||
AI431301 | aorta | .a | 3712 to 4126 | 460 to 46 | AAA | 415/415 (100 %) | 0 diff (100 %id) | ||
AI473781 | colon, moderately-differentiated adenocarcinoma | .a | 3710 to 4126 | 417 to 1 | 417/417 (100 %) | 0 diff (100 %id) | |||
AI479234 | Kidney | .a | 3629 to 4129 | 501 to 1 | 501/501 (100 %) | 0 diff (100 %id) | |||
AI500253 | anaplastic oligodendroglioma, brain | .a | 3708 to 4126 | 419 to 1 | 419/419 (100 %) | 0 diff (100 %id) | |||
AI560964 | anaplastic oligodendroglioma, brain | .a | 3659 to 4126 | 468 to 1 | 468/468 (100 %) | 0 diff (100 %id) | |||
AI912120 | carcinoid, lung | .a | 3713 to 4125 | 413 to 1 | 413/413 (100 %) | 1 diff (99.8 %id) | |||
AI692780 | carcinoid, lung | .a | 3713 to 4123 | 411 to 1 | 411/411 (100 %) | 0 diff (100 %id) | |||
AI692783 | carcinoid, lung | .a | 3586 to 4126 | 541 to 1 | 541/541 (100 %) | 1 diff (99.9 %id) | |||
AI769103 | pooled | .a | 3633 to 4126 | 508 to 15 | AAA | 494/494 (100 %) | 0 diff (100 %id) | ||
AI765925 | Kidney | .a | 1885 to 2337 | 466 to 13 | 454/466 (97 %) | 2 diff (99.6 %id) | |||
AI761804 | colon, colon tumor, RER+ | .a | 2569 to 3128 | 561 to 1 | 561/561 (100 %) | 5 diff (99.2 %id) | |||
AI869528 | anaplastic oligodendroglioma, brain | .a | 3805 to 4126 | 321 to 1 | 321/321 (100 %) | 1 diff (99.7 %id) | |||
AI925794 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .a | 3836 to 4126 | 303 to 12 | AAA | 292/401 (72 %) | 3 diff (99.3 %id) | ||
AI936955 | anaplastic oligodendroglioma, brain | .a | 1252 to 1669 | 422 to 5 | 418/422 (99 %) | 7 diff (98.4 %id) | |||
AI961161 | pooled germ cell tumors | .a | 3686 to 4128 | 443 to 1 | 443/443 (100 %) | 0 diff (100 %id) | |||
AI989624 | pooled germ cell tumors | .a | 3692 to 4125 | 434 to 1 | 434/434 (100 %) | 0 diff (100 %id) | |||
AW071704 | anaplastic oligodendroglioma, brain | .a | 3677 to 4126 | 451 to 1 | 451/451 (100 %) | 1 diff (99.8 %id) | |||
AW008413 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .a | 3706 to 4127 | 423 to 1 | 423/423 (100 %) | 1 diff (99.8 %id) | |||
AW075276 | anaplastic oligodendroglioma, brain | .a | 2819 to 3128 | 326 to 1 | 326/356 (91 %) | 16 diff (95.6 %id) | |||
AW474460 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .a | 3686 to 4126 | 441 to 1 | 441/441 (100 %) | 1 diff (99.8 %id) | |||
AW468519 | myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood | .a | 3709 to 4126 | 418 to 1 | 418/418 (100 %) | 0 diff (100 %id) | |||
AW593430 | pooled germ cell tumors | .a | 3733 to 4126 | 395 to 1 | 395/395 (100 %) | 8 diff (98.0 %id) | |||
BF507849 | .a | 3728 to 4126 | 416 to 18 | AAA | 399/409 (97 %) | 1 diff (99.8 %id) | |||
BF508025 | .e-u | 124 to 583 | 474 to 15 | D31E F53L | AAA | Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) | 460/471 (97 %) | 10 diff (97.9 %id) | |
CF134572 | CNCAP(3)T-225 cell line, Prostate | .a | 2958 to 3419 | 1 to 462 | 462/462 (100 %) | 1 diff (99.8 %id) | |||
BE466679 | pooled germ cell tumors | .a | 3692 to 4126 | 435 to 1 | 435/435 (100 %) | 0 diff (100 %id) | |||
BE504626 | pooled germ cell tumors | .a | 3688 to 4126 | 451 to 14 | AAA | 438/438 (100 %) | 2 diff (99.6 %id) | ||
BF432250 | brain, glioblastoma (pooled) | .a | 3648 to 4128 | 482 to 1 | 482/482 (100 %) | 9 diff (98.2 %id) | |||
BE644676 | pooled | .a | 3764 to 4131 | 372 to 5 | 368/372 (98 %) | 0 diff (100 %id) | |||
BE675257 | B-cell, chronic lymphotic leukemia | .a | 3680 to 4134 | 455 to 1 | 455/455 (100 %) | 2 diff (99.6 %id) | |||
BE675654 | B-cell, chronic lymphotic leukemia | .e-u | 160 to 584 | 423 to 1 | S17L K18R A19Q A20Q R21A ... | 423/423 (100 %) | 2 diff (99.6 %id) | ||
BE676083 | B-cell, chronic lymphotic leukemia | .e-u | 160 to 584 | 425 to 1 | exact | tiling clone, | 425/425 (100 %) | 0 diff (100 %id) | |
BE856761 | pooled | .a | 3576 to 4125 | 550 to 1 | 550/550 (100 %) | 1 diff (99.9 %id) | |||
BF055564 | pooled | .a | 3645 to 4131 | 490 to 4 | 487/490 (99 %) | 0 diff (100 %id) | |||
BF433898 | carcinoid, lung | .a | 3714 to 4127 | 414 to 1 | 414/414 (100 %) | 0 diff (100 %id) | |||
BE868389 | adenocarcinoma, colon | .a | 3082 to 3794 | 1 to 701 | 701/914 (76 %) | 22 diff (97.6 %id) | |||
BF107196 | placenta | .a | 3471 to 4138 | 1 to 661 | 661/707 (93 %) | 26 diff (96.4 %id) | |||
BF687939 | brain, glioblastoma | .a | 3778 to 4125 | 1 to 343 | AAA | 343/343 (100 %) | 11 diff (96.8 %id) | ||
BG106803 | lymph, lymphoma, cell line | .a | 3246 to 3996 | 1 to 740 | 740/928 (79 %) | 24 diff (97.5 %id) | |||
BG030182 | breast, mammary adenocarcinoma, cell line | .a | 1817 to 2528 | 29 to 740 | 712/1076 (66 %) | 18 diff (98.4 %id) | |||
BG033898 | breast, mammary adenocarcinoma, cell line | .a | 1509 to 2205 | 1 to 708 | 658/1079 (60 %) | 37 diff (96.6 %id) | |||
BC048309 | Duodenum, adenocarcinoma | .a | 2019 to 4126 | 1 to 2108 | available from MGC, AAA | 2108/2108 (100 %) | 0 diff (100 %id) | ||
BG116787 | duodenal adenocarcinoma, cell line, small intestine | .a | 2019 to 2782 | 1 to 767 | available from MGC, | 765/768 (99 %) | 18 diff (97.7 %id) | ||
BG119659 | adenocarcinoma, cell line, Liver | .a | 2878 to 3602 | 1 to 723 | 723/846 (85 %) | 8 diff (99.1 %id) | |||
BG163645 | hypernephroma, cell line, Kidney | .a | 2003 to 2778 | 1 to 774 | 774/959 (80 %) | 35 diff (96.4 %id) | |||
BG253674 | adenocarcinoma, cell line, Prostate | .a | 1663 to 2442 | 1 to 790 | 790/908 (87 %) | 12 diff (98.7 %id) | |||
BG255029 | adenocarcinoma, cell line, Prostate | .a | 3652 to 4131 | 1 to 481 | 481/494 (97 %) | 12 diff (97.6 %id) | |||
BC023255 | Bladder, transitional cell papilloma | .a | 1758 to 4126 | 1 to 2369 | available from MGC, AAA | 2369/2369 (100 %) | 0 diff (100 %id) | ||
BG287368 | bladder, transitional cell papilloma, cell line | .a | 1758 to 2528 | 1 to 779 | available from MGC, | 779/1064 (73 %) | 33 diff (96.9 %id) | ||
BG291961 | bladder, transitional cell papilloma, cell line | .a | 3532 to 4129 | 19 to 612 | AAA | 594/612 (97 %) | 6 diff (99.1 %id) | ||
BG614074 | embryonal carcinoma, testis | .a | 2143 to 2946 | 1 to 812 | 773/1046 (73 %) | 27 diff (97.5 %id) | |||
BG911133 | anaplastic oligodendroglioma with 1p/19qloss, brain | .a | 1465 to 2286 | 1 to 818 | 818/820 (99 %) | 13 diff (98.5 %id) | |||
BI253410 | cervical carcinoma cell line, cervix | .a | 1547 to 2223 | 1 to 677 | 677/677 (100 %) | 1 diff (99.9 %id) | |||
BI254803 | cervical carcinoma cell line, cervix | .a | 3953 to 4131 | 1 to 179 | 179/191 (93 %) | 1 diff (99.5 %id) | |||
BI254772 | cervical carcinoma cell line, cervix | .a | 3434 to 4129 | 1 to 694 | AAA | 694/694 (100 %) | 5 diff (99.3 %id) | ||
BM014435 | breast, mammary adenocarcinoma, cell line | .b | 3 to 827 | 1 to 829 | tiling clone, | 829/829 (100 %) | 7 diff (99.2 %id) | ||
BC111047 | Eye, retinoblastoma | .a | 340 to 4126 | 1 to 3787 | tiling clone, AAA | 3787/3787 (100 %) | 0 diff (100 %id) | ||
BM465327 | eye, retinoblastoma | .a | 334 to 1062 | 9 to 744 | 736/1015 (72 %) | 15 diff (98.6 %id) | |||
BM463660 | leiomyosarcoma, uterus | .a | 318 to 1247 | 1 to 927 | 927/1020 (90 %) | 23 diff (97.8 %id) | |||
BM806091 | leiomyosarcoma, uterus | .a | 2559 to 3501 | 12 to 954 | 943/1081 (87 %) | 13 diff (98.8 %id) | |||
BM806115 | leiomyosarcoma, uterus | .a | 2571 to 3469 | 23 to 938 | 916/1102 (83 %) | 42 diff (96.2 %id) | |||
BM905875 | leiomyosarcoma, uterus | .a | 2747 to 3732 | 1 to 997 | 997/998 (99 %) | 25 diff (97.5 %id) | |||
BM473699 | duodenal adenocarcinoma, cell line, small intestine | .a | 2799 to 3644 | 32 to 884 | 853/1195 (71 %) | 10 diff (99.2 %id) | |||
BM924403 | pooled colon, kidney, stomach | .a | 1528 to 2442 | 24 to 943 | 920/1088 (84 %) | 19 diff (98.3 %id) | |||
BQ050638 | leiomyosarcoma, uterus | .a | 1629 to 2319 | 1 to 694 | 692/1110 (62 %) | 11 diff (99.1 %id) | |||
BQ021324 | lung, Metastatic Chondrosarcoma | .a | 2510 to 3128 | 634 to 16 | AAA | Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) | 619/619 (100 %) | 0 diff (100 %id) | |
BQ009844 | Chondrosarcoma, Left Pubic Bone | .a | 3492 to 4126 | 653 to 19 | AAA | 635/635 (100 %) | 0 diff (100 %id) | ||
BU169926 | epithelioid carcinoma, Pancreas | .a | 1808 to 2637 | 1 to 831 | 831/832 (99 %) | 4 diff (99.6 %id) | |||
BQ424500 | leiomyosarcoma, uterus | .a | 1622 to 2417 | 1 to 805 | 805/864 (93 %) | 13 diff (98.5 %id) | |||
BQ440594 | leiomyosarcoma, uterus | .a | 509 to 1363 | 1 to 859 | 859/860 (99 %) | 8 diff (99.1 %id) | |||
BU172777 | eye, retinoblastoma | .a | 1358 to 2174 | 1 to 823 | 823/823 (100 %) | 12 diff (98.6 %id) | |||
BU195507 | leiomyosarcoma, uterus | .a | 941 to 1778 | 1 to 841 | 841/877 (95 %) | 9 diff (99.0 %id) | |||
BQ722309 | sympathetic trunk | .d | 1 to 894 | 1 to 891 | exact | tiling clone, | 891/894 (99 %) | 18 diff (98.0 %id) | |
BQ937699 | leiomyosarcoma, uterus | .a | 1641 to 2568 | 1 to 936 | 936/939 (99 %) | 19 diff (98.0 %id) | |||
BU928659 | brain, glioblastoma | .a | 2284 to 2999 | 1 to 727 | 727/768 (94 %) | 17 diff (97.8 %id) | |||
BU935524 | mixed (pool of 40 RNAs) | .b | 1080 to 1843 | 1 to 772 | tiling clone, | 772/775 (99 %) | 17 diff (97.9 %id) | ||
CB985443 | Pooled-Glandular | .a | 2256 to 2918 | 1 to 663 | 663/861 (77 %) | 6 diff (99.4 %id) | |||
CB991226 | placenta, pre-eclamptic placenta | .a | 26 to 570 | 23 to 564 | 542/618 (87 %) | 16 diff (97.5 %id) | |||
CD244439 | testis | .a | 837 to 1630 | 1 to 799 | 799/886 (90 %) | 12 diff (98.7 %id) | |||
CD556733 | brain, Pituitary | .a | 2827 to 3650 | 23 to 860 | 838/905 (92 %) | 20 diff (97.8 %id) | |||
CD514208 | White Matter | .a | 2827 to 3629 | 1 to 815 | 815/931 (87 %) | 19 diff (98.0 %id) | |||
CD522836 | pooled | .a | 1917 to 2660 | 1 to 756 | 756/756 (100 %) | 14 diff (98.2 %id) | |||
CD655006 | Embryonic Stem cells | .a | 1236 to 2010 | 1 to 764 | 764/854 (89 %) | 20 diff (97.7 %id) | |||
CF243078 | Brain glioblastoma | .a | 1502 to 2286 | 1 to 789 | 789/864 (91 %) | 6 diff (99.4 %id) | |||
TI_59392453 | .b | 1 to 827 | 85 to 915 | tiling clone, | 831/831 (100 %) | 7 diff (99.2 %id) | |||
CB122355 | Liver | .a | 3073 to 3634 | 1 to 562 | 562/562 (100 %) | 2 diff (99.7 %id) | |||
BP428632 | .a | 3096 to 3494 | 1 to 399 | 399/399 (100 %) | 2 diff (99.5 %id) | ||||
DA642475 | Liver | .a | 1561 to 2133 | 2 to 574 | capped | 573/573 (100 %) | 0 diff (100 %id) | ||
DB321352 | Liver | .a | 3583 to 4126 | 545 to 1 | 545/545 (100 %) | 1 diff (99.9 %id) | |||
BY993975 | .a | 1554 to 2122 | 13 to 581 | 569/581 (97 %) | 7 diff (98.8 %id) | ||||
NM_152716.2 | .a | 2 to 4126 | 1 to 4125 | exact | RefSeq, AAA | 4125/4125 (100 %) | 0 diff (100 %id) | ||
DA730602 | .a | 2211 to 3039 | 2 to 826 | capped | 825/825 (100 %) | 9 diff (99.0 %id) | |||
DB362494 | .a | 3533 to 4126 | 591 to 1 | 591/595 (99 %) | 7 diff (98.9 %id) | ||||
DA737640 | .a | 509 to 1323 | 2 to 816 | capped | 815/817 (99 %) | 10 diff (98.8 %id) | |||
DB370248 | .a | 2552 to 3128 | 577 to 1 | 577/577 (100 %) | 12 diff (98.0 %id) | ||||
DA748976 | .a | 1773 to 2335 | 2 to 564 | capped | 563/563 (100 %) | 1 diff (99.9 %id) | |||
CV570019 | cornea, eye | .a | 2542 to 3150 | 1 to 609 | 609/609 (100 %) | 0 diff (100 %id) | |||
D20653 | .a | 3651 to 3700 | 1 to 50 | Submitted on the opposite strand | 50/52 (96 %) | 1 diff (98.1 %id) | |||
CR989949 | T-Lymphocytes | .a | 57 to 403 | 1 to 347 | 347/347 (100 %) | 5 diff (98.6 %id) | |||
BM742405 | Ascites, stomach | .a | 3735 to 4126 | 1 to 392 | AAA | 392/392 (100 %) | 0 diff (100 %id) | ||
BM855046 | stomach | .a | 3788 to 4126 | 1 to 339 | AAA | 339/339 (100 %) | 0 diff (100 %id) | ||
BM821979 | stomach | .a | 3813 to 4028 | 1 to 217 | 217/217 (100 %) | 2 diff (99.1 %id) | |||
BM822937 | stomach | .a | 3788 to 4126 | 1 to 339 | AAA | 339/339 (100 %) | 0 diff (100 %id) | ||
BM829812 | stomach | .a | 2320 to 2758 | 1 to 439 | 439/439 (100 %) | 2 diff (99.6 %id) | |||
BM830062 | stomach | .a | 3788 to 4126 | 1 to 339 | AAA | 339/339 (100 %) | 0 diff (100 %id) | ||
BM830142 | stomach | .a | 3788 to 4126 | 1 to 339 | AAA | 339/339 (100 %) | 0 diff (100 %id) | ||
DA992102 | synovial membrane tissue from rheumatioidarthritis | .a | 43 to 367 | 2 to 326 | capped | 325/325 (100 %) | 0 diff (100 %id) | ||
DR002775 | fetal brain | .a | 513 to 1000 | 8 to 494 | 487/494 (98 %) | 13 diff (97.4 %id) | |||
DR001504 | fetal brain | .a | 25 to 702 | 1 to 678 | 678/678 (100 %) | 4 diff (99.5 %id) | |||
DB089564 | testis | .a | 61 to 630 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
DB137839 | thymus | .a | 25 to 213 | 2 to 190 | capped | 189/189 (100 %) | 0 diff (100 %id) | ||
DC409866 | thymus | .a | 2 to 603 | 1 to 602 | 602/602 (100 %) | 0 diff (100 %id) | |||
TI_154062325 | .a | 3261 to 4126 | 934 to 79 | AAA | 856/934 (91 %) | 24 diff (97.5 %id) | |||
TI_154162602 | .a | 2927 to 3499 | 61 to 641 | 581/1196 (48 %) | 15 diff (98.8 %id) | ||||
DB167485 | kidney, tumor tissue | .a | 1 to 550 | 2 to 551 | capped | 550/550 (100 %) | 1 diff (99.9 %id) | ||
DB225444 | trachea | .a | 484 to 1036 | 2 to 554 | capped | 553/553 (100 %) | 0 diff (100 %id) | ||
BM691639 | eye, RPE and Choroid | .a | 3617 to 4131 | 545 to 31 | Submitted on the opposite strand | 515/545 (94 %) | 0 diff (100 %id) | ||
BM929899 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 2563 to 2871 | 1 to 309 | 309/309 (100 %) | 0 diff (100 %id) | |||
BQ773067 | Chondrosarcoma Cell line | .a | 3499 to 4126 | 645 to 19 | AAA | 627/627 (100 %) | 2 diff (99.7 %id) | ||
CA421114 | Bone, Enchondroma cell line | .a | 3523 to 4126 | 621 to 19 | AAA | 603/603 (100 %) | 1 diff (99.9 %id) | ||
CA421807 | Bone, Enchondroma cell line | .a | 3479 to 4126 | 666 to 19 | AAA | 648/648 (100 %) | 0 diff (100 %id) | ||
BU626719 | Alveolar Macrophage, lung | .a | 3478 to 4126 | 667 to 19 | AAA | 649/649 (100 %) | 2 diff (99.7 %id) | ||
DB257506 | uterus | .a | 1975 to 2483 | 2 to 510 | capped | 509/509 (100 %) | 0 diff (100 %id) | ||
DC298844 | adrenal gland | .a | 1629 to 2319 | 1 to 694 | Suspected internal deletion, this clone was ignored | 692/1110 (62 %) | 11 diff (99.1 %id) | ||
AK127943 | synovial membrane tissue from rheumatioidarthritis | .a | 1629 to 2319 | 1 to 694 | available from FLJ, | Suspected internal deletion, this clone was ignored | 692/1110 (62 %) | 11 diff (99.1 %id) | |
AK293213 | adrenal gland | .a | 2510 to 3128 | 634 to 16 | Suspected internal deletion, this clone was ignored | 619/619 (100 %) | 0 diff (100 %id) | ||
AA219236 | brain, neuroepithelial cells | .a | 2510 to 3128 | 634 to 16 | This clone was ignored | 619/619 (100 %) | 0 diff (100 %id) | ||
AA262262 | germinal center B cell | .a | 3492 to 4126 | 653 to 19 | This clone was ignored | 635/635 (100 %) | 0 diff (100 %id) | ||
AA262873 | germinal center B cell | .a | 3492 to 4126 | 653 to 19 | This clone was ignored | 635/635 (100 %) | 0 diff (100 %id) | ||
BU169926 | epithelioid carcinoma, Pancreas | .a | 1808 to 2637 | 1 to 831 | 831/832 (99 %) | 4 diff (99.6 %id) | |||
BU169926 | epithelioid carcinoma, Pancreas | .a | 1808 to 2637 | 1 to 831 | 831/832 (99 %) | 4 diff (99.6 %id) | |||
BQ424500 | leiomyosarcoma, uterus | .a | 1622 to 2417 | 1 to 805 | 805/864 (93 %) | 13 diff (98.5 %id) | |||
BQ424500 | leiomyosarcoma, uterus | .a | 1622 to 2417 | 1 to 805 | 805/864 (93 %) | 13 diff (98.5 %id) | |||
BQ440594 | leiomyosarcoma, uterus | .a | 509 to 1363 | 1 to 859 | 859/860 (99 %) | 8 diff (99.1 %id) | |||
BQ440594 | leiomyosarcoma, uterus | .a | 509 to 1363 | 1 to 859 | 859/860 (99 %) | 8 diff (99.1 %id) | |||
BU172777 | eye, retinoblastoma | .a | 1358 to 2174 | 1 to 823 | 823/823 (100 %) | 12 diff (98.6 %id) | |||
BU172777 | eye, retinoblastoma | .a | 1358 to 2174 | 1 to 823 | 823/823 (100 %) | 12 diff (98.6 %id) | |||
BU195507 | leiomyosarcoma, uterus | .a | 941 to 1778 | 1 to 841 | 841/877 (95 %) | 9 diff (99.0 %id) | |||
BU195507 | leiomyosarcoma, uterus | .a | 941 to 1778 | 1 to 841 | 841/877 (95 %) | 9 diff (99.0 %id) | |||
BQ722309 | sympathetic trunk | .d | 1 to 894 | 1 to 891 | exact | tiling clone, | 891/894 (99 %) | 18 diff (98.0 %id) | |
BQ937699 | leiomyosarcoma, uterus | .a | 1641 to 2568 | 1 to 936 | 936/939 (99 %) | 19 diff (98.0 %id) | |||
BQ937699 | leiomyosarcoma, uterus | .a | 1641 to 2568 | 1 to 936 | 936/939 (99 %) | 19 diff (98.0 %id) | |||
BU928659 | brain, glioblastoma | .a | 2284 to 2999 | 1 to 727 | 727/768 (94 %) | 17 diff (97.8 %id) | |||
BU928659 | brain, glioblastoma | .a | 2284 to 2999 | 1 to 727 | 727/768 (94 %) | 17 diff (97.8 %id) | |||
BU935524 | mixed (pool of 40 RNAs) | .b | 1080 to 1843 | 1 to 772 | tiling clone, | 772/775 (99 %) | 17 diff (97.9 %id) | ||
CB985443 | Pooled-Glandular | .a | 2256 to 2918 | 1 to 663 | 663/861 (77 %) | 6 diff (99.4 %id) | |||
CB991226 | placenta, pre-eclamptic placenta | .a | 26 to 570 | 23 to 564 | 542/618 (87 %) | 16 diff (97.5 %id) | |||
CB991226 | placenta, pre-eclamptic placenta | .a | 26 to 570 | 23 to 564 | 542/618 (87 %) | 16 diff (97.5 %id) | |||
CD244439 | testis | .a | 837 to 1630 | 1 to 799 | 799/886 (90 %) | 12 diff (98.7 %id) | |||
CD556733 | brain, Pituitary | .a | 2827 to 3650 | 23 to 860 | 838/905 (92 %) | 20 diff (97.8 %id) | |||
CD556733 | brain, Pituitary | .a | 2827 to 3650 | 23 to 860 | 838/905 (92 %) | 20 diff (97.8 %id) | |||
CD514208 | White Matter | .a | 2827 to 3629 | 1 to 815 | 815/931 (87 %) | 19 diff (98.0 %id) | |||
CD522836 | pooled | .a | 1917 to 2660 | 1 to 756 | 756/756 (100 %) | 14 diff (98.2 %id) | |||
CD655006 | Embryonic Stem cells | .a | 1236 to 2010 | 1 to 764 | 764/854 (89 %) | 20 diff (97.7 %id) | |||
CF243078 | Brain glioblastoma | .a | 1502 to 2286 | 1 to 789 | 789/864 (91 %) | 6 diff (99.4 %id) | |||
TI_59392453 | .b | 1 to 827 | 85 to 915 | tiling clone, | 831/831 (100 %) | 7 diff (99.2 %id) | |||
CB122355 | Liver | .a | 3073 to 3634 | 1 to 562 | 562/562 (100 %) | 2 diff (99.7 %id) | |||
BP428632 | .a | 3096 to 3494 | 1 to 399 | 399/399 (100 %) | 2 diff (99.5 %id) | ||||
DA642475 | Liver | .a | 1561 to 2133 | 2 to 574 | capped | 573/573 (100 %) | 0 diff (100 %id) | ||
DB321352 | Liver | .a | 3583 to 4126 | 545 to 1 | 545/545 (100 %) | 1 diff (99.9 %id) | |||
BY993975 | .a | 1554 to 2122 | 13 to 581 | 569/581 (97 %) | 7 diff (98.8 %id) | ||||
NM_152716.2 | .a | 2 to 4126 | 1 to 4125 | exact | RefSeq, AAA | 4125/4125 (100 %) | 0 diff (100 %id) | ||
DA730602 | .a | 2211 to 3039 | 2 to 826 | capped | 825/825 (100 %) | 9 diff (99.0 %id) | |||
DB362494 | .a | 3533 to 4126 | 591 to 1 | 591/595 (99 %) | 7 diff (98.9 %id) | ||||
DA737640 | .a | 509 to 1323 | 2 to 816 | capped | 815/817 (99 %) | 10 diff (98.8 %id) | |||
DB370248 | .a | 2552 to 3128 | 577 to 1 | 577/577 (100 %) | 12 diff (98.0 %id) | ||||
DA748976 | .a | 1773 to 2335 | 2 to 564 | capped | 563/563 (100 %) | 1 diff (99.9 %id) | |||
CV570019 | cornea, eye | .a | 2542 to 3150 | 1 to 609 | 609/609 (100 %) | 0 diff (100 %id) | |||
CV570019 | cornea, eye | .a | 2542 to 3150 | 1 to 609 | 609/609 (100 %) | 0 diff (100 %id) | |||
D20653 | .a | 3651 to 3700 | 1 to 50 | Submitted on the opposite strand | 50/52 (96 %) | 1 diff (98.1 %id) | |||
CR989949 | T-Lymphocytes | .a | 57 to 403 | 1 to 347 | 347/347 (100 %) | 5 diff (98.6 %id) | |||
BM742405 | Ascites, stomach | .a | 3735 to 4126 | 1 to 392 | AAA | 392/392 (100 %) | 0 diff (100 %id) | ||
BM742405 | Ascites, stomach | .a | 3735 to 4126 | 1 to 392 | AAA | 392/392 (100 %) | 0 diff (100 %id) | ||
BM855046 | stomach | .a | 3788 to 4126 | 1 to 339 | AAA | 339/339 (100 %) | 0 diff (100 %id) | ||
BM821979 | stomach | .a | 3813 to 4028 | 1 to 217 | 217/217 (100 %) | 2 diff (99.1 %id) | |||
BM822937 | stomach | .a | 3788 to 4126 | 1 to 339 | AAA | 339/339 (100 %) | 0 diff (100 %id) | ||
BM829812 | stomach | .a | 2320 to 2758 | 1 to 439 | 439/439 (100 %) | 2 diff (99.6 %id) | |||
BM830062 | stomach | .a | 3788 to 4126 | 1 to 339 | AAA | 339/339 (100 %) | 0 diff (100 %id) | ||
BM830142 | stomach | .a | 3788 to 4126 | 1 to 339 | AAA | 339/339 (100 %) | 0 diff (100 %id) | ||
DA992102 | synovial membrane tissue from rheumatioidarthritis | .a | 43 to 367 | 2 to 326 | capped | 325/325 (100 %) | 0 diff (100 %id) | ||
DR002775 | fetal brain | .a | 513 to 1000 | 8 to 494 | 487/494 (98 %) | 13 diff (97.4 %id) | |||
DR001504 | fetal brain | .a | 25 to 702 | 1 to 678 | 678/678 (100 %) | 4 diff (99.5 %id) | |||
DB089564 | testis | .a | 61 to 630 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
DB137839 | thymus | .a | 25 to 213 | 2 to 190 | capped | 189/189 (100 %) | 0 diff (100 %id) | ||
DC409866 | thymus | .a | 2 to 603 | 1 to 602 | 602/602 (100 %) | 0 diff (100 %id) | |||
TI_154062325 | .a | 3261 to 4126 | 934 to 79 | AAA | 856/934 (91 %) | 24 diff (97.5 %id) | |||
TI_154162602 | .a | 2927 to 3499 | 61 to 641 | 581/1196 (48 %) | 15 diff (98.8 %id) | ||||
DB167485 | kidney, tumor tissue | .a | 1 to 550 | 2 to 551 | capped | 550/550 (100 %) | 1 diff (99.9 %id) | ||
DB225444 | trachea | .a | 484 to 1036 | 2 to 554 | capped | 553/553 (100 %) | 0 diff (100 %id) | ||
BM691639 | eye, RPE and Choroid | .a | 3617 to 4131 | 545 to 31 | Submitted on the opposite strand | 515/545 (94 %) | 0 diff (100 %id) | ||
BM691639 | eye, RPE and Choroid | .a | 3617 to 4131 | 545 to 31 | Submitted on the opposite strand | 515/545 (94 %) | 0 diff (100 %id) | ||
BM929899 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 2563 to 2871 | 1 to 309 | 309/309 (100 %) | 0 diff (100 %id) | |||
BM929899 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 2563 to 2871 | 1 to 309 | 309/309 (100 %) | 0 diff (100 %id) | |||
BQ773067 | Chondrosarcoma Cell line | .a | 3499 to 4126 | 645 to 19 | AAA | 627/627 (100 %) | 2 diff (99.7 %id) | ||
CA421114 | Bone, Enchondroma cell line | .a | 3523 to 4126 | 621 to 19 | AAA | 603/603 (100 %) | 1 diff (99.9 %id) | ||
CA421114 | Bone, Enchondroma cell line | .a | 3523 to 4126 | 621 to 19 | AAA | 603/603 (100 %) | 1 diff (99.9 %id) | ||
CA421807 | Bone, Enchondroma cell line | .a | 3479 to 4126 | 666 to 19 | AAA | 648/648 (100 %) | 0 diff (100 %id) | ||
CA421807 | Bone, Enchondroma cell line | .a | 3479 to 4126 | 666 to 19 | AAA | 648/648 (100 %) | 0 diff (100 %id) | ||
BU626719 | Alveolar Macrophage, lung | .a | 3478 to 4126 | 667 to 19 | AAA | 649/649 (100 %) | 2 diff (99.7 %id) | ||
BU626719 | Alveolar Macrophage, lung | .a | 3478 to 4126 | 667 to 19 | AAA | 649/649 (100 %) | 2 diff (99.7 %id) | ||
DB257506 | uterus | .a | 1975 to 2483 | 2 to 510 | capped | 509/509 (100 %) | 0 diff (100 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e-u | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes C |